LABORATORY CORP OF AMERICA HOLDINGS 4
4 · LABORATORY CORP OF AMERICA HOLDINGS · Filed Mar 15, 2016
Insider Transaction Report
Form 4
Tanner Deborah L
CEO, Covance Drug Development
Transactions
- Exercise/Conversion
Common Stock
2016-03-11+11,710→ 23,967 total - Tax Payment
Common Stock
2016-03-11$115.49/sh−4,213$486,559→ 19,754 total - Exercise/Conversion
Restricted Stock Unit
2016-03-11−1,220→ 29,980 total→ Common Stock (1,220 underlying) - Exercise/Conversion
Common Stock
2016-03-11+1,220→ 12,632 total - Tax Payment
Common Stock
2016-03-11$115.49/sh−374$43,193→ 12,257 total - Exercise/Conversion
Restricted Stock Unit
2016-03-11−11,710→ 18,270 total→ Common Stock (11,710 underlying)
Footnotes (5)
- [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- [F2]Stock withholding to satisfy tax withholding obligations.
- [F3]The Restricted Stock Units vest in three equal annual installments beginning on 3/11/16.
- [F4]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- [F5]The Restricted Stock Units vest in two equal annual installments beginning on 3/11/16.